Key Players
Competitive Landscape
Competition in phosphatidylserine is increasingly based on formulation usability rather than basic ingredient availability. Nutraceutical manufacturers need a dependable concentration that performs consistently during blending, encapsulation, or other finished-product processing. Source declarations also matter when brands differentiate between soy, sunflower, and other feedstocks. A supplier that can provide several formats has more opportunities to follow the same customer from a capsule concept into powder, food, beverage, or beauty-oriented formulations.
Chemi Nutra and IFF compete from different branded platforms but address similar buyer needs. SerinAid is positioned around phosphatidylserine ingredient supply and application support, while Sharp-PS provides several concentrations and physical formats across wellness applications. The commercial distinction comes from source choice, dispersibility, dose concentration, technical support, and the ability to provide a specification that can be transferred efficiently into the customer's finished-product system.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| Chemi Nutra's current SerinAid portfolio supports powders, capsules, functional foods, and ready-to-drink applications. | Brands want to carry cognitive-health ingredients across more than one finished-product format. | Branded PS suppliers are extending formulation support beyond conventional capsules. | Serve customers moving into powders, functional foods, and beverage-based wellness products. |
| IFF's Sharp-PS portfolio includes powder, fine-powder, and dispersion formats across multiple concentrations. | Formulators need different physical properties for different product systems. | Ingredient platforms are becoming more format-specific rather than relying on one standard grade. | Match PS concentration and physical form more closely with manufacturing requirements. |
| IFF positions Sharp-PS across brain-health and beauty-oriented applications. | Wellness brands are combining cognitive, healthy-aging, and beauty propositions. | PS is moving into broader multi-benefit formulation concepts. | Extend ingredient demand into beauty-from-within and other adjacent wellness products. |
The competitive opportunity is therefore application-specific. Powder suppliers benefit from the dominant dry supplement channel, while dispersible material creates additional routes into food and beverage development. Plant-based sourcing provides another differentiation point where a finished brand wants to avoid animal-derived ingredients.
How do profiled companies differ in competitive positioning?
Chemi Nutra competes through the SerinAid branded platform with strong emphasis on nutraceutical formulation and functional-food compatibility. IFF's Sharp-PS portfolio combines source and format flexibility with applications spanning brain health and other wellness concepts. Both compete on technical support and standardized material rather than commodity phospholipid supply.
What qualification or purchasing requirements matter most?
Buyers typically compare standardized PS concentration, source identity, powder or liquid behavior, batch consistency, and documentation required for the destination market. A specification that works in a capsule may not automatically provide the same processing performance in a beverage or food system, making application testing important before commercial scale-up.
Which product capabilities are most commercially relevant?
Concentrated powder remains important because it fits the largest Nutraceutical End Use segment. Fine powders and dispersions provide additional options for products where flow, mixing, or incorporation into a liquid system matters. Plant-based source choice also helps brands align ingredient selection with vegetarian or other non-animal product positioning.
How does geographic reach differ across the profiled companies?
Chemi Nutra operates from the United States while supporting ingredient customers across multiple formulation channels. IFF uses its international health-sciences platform to commercialize Sharp-PS across a broader global customer network. In both cases, actual product selection still depends on the formulation and regulatory requirements of the destination market.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Chemi Nutra | Branded phosphatidylserine ingredient specialist serving nutraceutical and functional-food formulations through SerinAid. | Current SerinAid application support spans powders, capsules, functional foods, and ready-to-drink formulations. |
| IFF | Global health-sciences ingredient supplier offering Sharp-PS across source, concentration, format, and wellness applications. | Current Sharp-PS offerings include powder, fine powder, and dispersion formats and extend across brain-health and beauty applications. |
Research Methodology
Competitive mapping uses current branded phosphatidylserine portfolios, product specifications, formulation applications, 2025-2026 regulatory developments, and current company information. Benchmark ratings describe the stated commercial capabilities and do not represent company market shares. Company positioning is limited to roles directly connected with phosphatidylserine ingredients and in-scope formulation support.
